Bataluna, Karen .

HRN: 29-05-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/25/2026
07/27/2026
IV
500mg
Q8hr X 4 Doses
Sp PLTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: